Found vs Eden
Two nationwide services within thirty dollars of each other.
Found
Editorial
$169/mo
One compounded GLP-1 plan bundling medication, membership and coaching, where the questionnaire and the prescriber decide which molecule a reader receives. The twelve-month prepaid cash rate is $169 a month against $289 paying as you go. Brand figures disagree between the homepage carousel and the medication table.
Pick it for: Buyers who want the lower opening figure
Eden
Editorial
$198/mo
Compounded semaglutide and compounded tirzepatide by injection, each priced as medication alone at $99 and $199 a month. The Eden Membership is a further $99 and the GLP-1 page states it is required, so one month is $198 or $298. The rate is stated to hold at every dose across 50 states.
Pick it for: Buyers who want the rate stated as flat before committing
Our verdict
Found opens at $169 and Eden at $198, both across fifty states. Eden states its rate holds; Found does not say.
What actually separates them
Found and Eden state different things about published price. Everything else they publish, they publish the same way.
Eden costs $29 more than Found — 17% more for the same molecule. Whether that buys anything is what the rest of this page is for.
Over twelve months that is about $2,028 at Found against $2,376 at Eden — a difference of $348.
| Found | Eden | |
|---|---|---|
| Published price | $169/mo | $198/mo |
Before you choose either
Ask both sellers what dose the monthly price buys before you compare the two figures. A price is only a price once you know what quantity it is attached to, and a seller that will not answer has told you something. Set both against every published price we hold rather than against each other alone.
Our take is computed from a published rubric that does not read commercial status, and what is known about safety applies to both of them equally.